(Q44161639)

30 November 2017

title

Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia (English)

1 reference

autoimmune hemolytic anemia

30 November 2017

1 reference

1 reference

1 reference

Gupta N

1

1 reference

30 November 2017

Kavuru S

2

1 reference

30 November 2017

Patel D

3

1 reference

30 November 2017

Janson D

4

1 reference

30 November 2017

Driscoll N

5

1 reference

30 November 2017

Ahmed S

6

1 reference

30 November 2017

Rai KR

7

1 reference

30 November 2017

publication date

1 October 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

16

1 reference

30 November 2017

issue

10

1 reference

30 November 2017

page(s)

2092-2095

1 reference

Autoimmunity in chronic lymphocytic leukaemia

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402676

7 January 2021

Successful treatment of autoimmune hemolytic anemia in common variable immunodeficiency with high-dose intravenous gamma globulin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402676

7 January 2021

B-cell chronic lymphocytic leukemia: a bird of a different feather

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402676

7 January 2021

A unique cell surface antigen identifying lymphoid malignancies of B cell origin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402676

7 January 2021

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402676

7 January 2021

Rituximab therapy of patients with B-cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402676

7 January 2021

Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402676

7 January 2021

Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402676

7 January 2021

Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402676

7 January 2021

Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402676

7 January 2021

Hemolytic anemia after fludarabine therapy for chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402676

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2402676

1 reference

30 November 2017

1 reference